Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics -  - Books - Springer Nature Switzerland AG - 9783030098179 - February 2, 2019
In case cover and title do not match, the title is correct

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition

Price
$ 157.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 2 - 8
Add to your iMusic wish list

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.


242 pages, 22 Illustrations, color; XX, 242 p. 22 illus. in color.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released February 2, 2019
ISBN13 9783030098179
Publishers Springer Nature Switzerland AG
Pages 242
Dimensions 150 × 220 × 10 mm   ·   406 g
Language German  
Editor Elkabets, Moshe
Editor Yarden, Yosef

Mere med samme udgiver